Cargando…
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer
SIMPLE SUMMARY: Despite the clinical benefit of new anticancer therapies, such as immune checkpoint inhibitors, lung cancer remains the most frequent cause of cancer-related death worldwide, thus supporting the need to develop novel anticancer treatments. Endothelial cells of the tumor-associated va...
Autores principales: | Valério-Fernandes, Ângela, Fonseca, Nuno A., Gonçalves, Nélio, Cruz, Ana F., Pereira, Marta I., Gregório, Ana C., Moura, Vera, Ladeirinha, Ana F., Alarcão, Ana, Gonçalves, Joana, Abrunhosa, Antero, Melo, Joana B., Carvalho, Lina, Simões, Sérgio, Moreira, João N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101044/ https://www.ncbi.nlm.nih.gov/pubmed/35565346 http://dx.doi.org/10.3390/cancers14092217 |
Ejemplares similares
-
The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway
por: Cruz, Ana F., et al.
Publicado: (2021) -
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
por: Carvalho, Laura Sofia, et al.
Publicado: (2021) -
Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
por: Romano, Sofia, et al.
Publicado: (2018) -
Metabolic responses of A549 lung cells to cisplatin and radiation exposure studied by (1)H NMR spectroscopy
por: Ladeirinha, Ana F, et al.
Publicado: (2010) -
Nanoemulsions for Enhancement of Curcumin Bioavailability and Their Safety Evaluation: Effect of Emulsifier Type
por: Gonçalves, Raquel F. S., et al.
Publicado: (2021)